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Biotech aesthetics: exploring the practice of bio art 
 
Abstract 
Advances in biotechnology include contemporary artists working in laboratories to 
create living and semi-living works of art. This paper offers an account of how bio art 
can be read as an emerging contemporary art practice of the early twenty-first century.  
This draws on the art-historical precedent of Marcel Duchamp, who transformed 
objects from commonplace existence into works of art, and contemporary theories of 
art. Empirical data, in the form of interviews with leading bio art practitioners Oron 
Catts, Eduardo Kac, Kira O’Reilly, Stelarc and Paul Vanouse, are used to study how 
artists navigate between disciplines. In doing so, we discuss bio art as a critical 
practice based on a communal ethos.  
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Biotech aesthetics: exploring the practice of bio art 
 
‘[T]he withdrawal of the experience of aesthetic pleasure from art’ 
– Alexander Alberro on the meaning of conceptual art, October 70 
(Autumn 1994, 132).  
 
An introduction to bio art  
Advances in biotechnology are rapid, with the challenge of manipulating human 
nature so imminent that the dialogue can no longer be reserved for scientists. Indeed 
theorist Eugene Thacker (in Thacker and Ruiz 2006, 5) has invited research on ‘the 
aesthetics of the biotech industry’, and contemporary artists are making a contribution 
by exploring just this permeability between disciplines. Works of art made from 
living and semi-living materials – so-called bio art – suggest that something intriguing 
is taking place. Examples from Eduardo Kac and Julia Reodica, two bio art 
practitioners, illustrate the convergence of art, science and technology that is central 
to this paper on biotech aesthetics.   
In 2000 Chicago-based artist Eduardo Kac, working in a research laboratory in 
France, the Institut National de la Recherche Agronomique (INRA), modified the 
genome of a rabbit embryo to accept genetic material from a jellyfish; the embryo was 
then gestated to become a rabbit with a capacity to glow fluorescent green under 
ultraviolet lighting conditions. Kac was using biotechnology in collaboration with 
scientists in order to create an independent, living work of art: GFP Bunny (2000), 
which refers to ‘green fluorescent protein’, is one of the most recognizable works of 
bio art. [INSERT IMAGE 1] Kac wanted Alba, as the transgenic rabbit was known, to 
integrate into society starting with his family. This was to underscore the role genetic 
engineering plays in our normal, domestic lives. Kac (2003, 97) notes that transgenic 
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art ‘must be done with great care, with acknowledgement of the complex issues thus 
raised, and above all, with a commitment to respect, nurture and love the life created’.  
Kac’s art object remains controversial. The INRA refused to release Alba. Kac 
responded by creating an entire GFP Bunny series of works. Sceptical observers have 
questioned Kac’s working methods, including the lack of full disclosure associated 
with the relevant scientific research. For example, Ellen Levy (2006; 2007) has 
questioned whether claims that artificial life has created self-replicating evolving 
entities are credible. ‘From an ethical point of view’, according to Levy (2006, 201), 
‘it still matters whether genetic engineering had occurred’. In doing so, Levy (2007, 
4) also acknowledges that ‘there is real value to artists investigating biology through 
synthetic means’. 
Julia Reodica’s hymNext project (initiated in 2004-05) has the self-described 
‘medical artist’ incorporating her own body cells into the sculptures: ‘The hymen 
tissue cultures were a combination of my vaginal cells, rodent smooth muscle tissue 
and bovine collagen scaffolding grown in nutrient media’ (Reodica 2007, 415). 
Reodica’s project was featured in an issue of New Literary History (Davis and Morris 
2007) devoted to ‘biocultures’, that is the multiple convergences of the biological and 
the cultural. [INSERT IMAGE 2] As part of her artist’s statement, Reodica (2007, 
415) emphasizes the bio art agenda: ‘My cells are in the sculpture because I wanted 
myself to be new art media. In each sculpture, my DNA is a personal signature’. 
Sculpted from the artist’s own vaginal cells, hymNext is an opportunity for Reodica to 
question the traditional value of virginity. She does so at a time when the tissue 
representing the hymen can be easily recreated and implanted. Repeated events of 
defloration are perhaps still abhorrent to many. As Barbara Kruger (1989) has 
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reminded us, bodies are biological and cultural.1  The body remains a battleground, a 
contested site where many cultural discourses are debated.      
As such, bio art practitioners like Kac and Reodica represent an attempt to 
reconcile the split between art and nature. They are posing questions of how 
biotechnology alters our relations to the world.  ‘What does it mean for a society to 
bring into existence a rabbit that glows green?’ (Tomasula 2002, 138). Are bio art 
practitioners transgressors challenging ‘western edifices of humanity and humanism’? 
(Puncer 2008, 478; see also Rifkin 2003). Or is bio art, as suggested by Levy (2007, 
15), ‘one way to acclimatize the public to new scientific discoveries and new 
technologies’?  
In this paper on biotech aesthetics, attention is devoted to a group of artists. 
This reflects a fundamental condition of bio art, namely that its practitioners view 
themselves as contemporary artists with their agenda grounded in artistic practices. 
The next section defines bio and bio art as they are is used here, which includes 
reference to Donna Haraway’s (1997) ‘technoscience’ and Hal Foster’s (1983) ‘anti-
aesthetic’. This is followed by our methodological statement, namely why and how 
five artists – Oron Catts of SymbioticA, Eduardo Kac, Kira O’Reilly, Stelarc and Paul 
Vanouse – are used as a point of entry into bio art practices. Biotech aesthetics is 
contextualized, in the fourth section, with reference to the art-historical precedent of 
Marcel Duchamp and more recent theorists of art. Drawing on the interview data, 
three domains emerge with a shared focus on bio art and its practitioners. Artists 
talking about bio art is a starting point: it includes questions regarding how the artists 
define the practice of bio art and their works in relation to that of their 
contemporaries. The second domain addresses art and science intersections: what role 
does bio art play in science? What role does science play in bio art? Can they inform 
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one another? The distribution and reception of bio art is the third domain. What is 
exhibited given the ‘liveness’ of bio art? What matters to the artists? This addresses 
the importance of critical and public reception for bio art practitioners. In the final 
section of the paper we draw conclusions on bio art as a critical practice based on a 
communal ethos.  
 
Defining bio and bio art 
 
‘Art, science, and technology are culturally laden terms’ (Wilson 2002, 11), which 
suggests that distinctions should be made between them before defining bio and bio 
art. ‘Science and technology are sometimes conflated together’ (Wilson 2002, 11), yet 
science and technology are not the same. Whereas ‘technology is seen as “knowing 
how”’ (such as the process of inventing and making things), ‘science is seen as 
“knowing why”’ (Wilson 2002, 12). Donna Haraway (1997, 50) adopts a different 
stance, though, as she ‘mimes the implosion of science and technology into each 
other’. ‘Technoscience’ serves as a ‘condensed signifier’; moreover, it is a 
‘heterogeneous cultural practice’ that ‘should not be narrated or engaged only from 
the points of area of those called scientists or engineers’ (Haraway 1997, 50). This 
invites contemporary artists ‘to take responsibilities for the social relationships of 
science and technology’, a theme in ‘the cyborg myth’, as first advanced in the mid-
1980s (Haraway 1991). Haraway’s (1991, 154 and 181) earlier work on the cyborg is 
‘about transgressed boundaries, potent fusions, and dangerous possibilities’, with a 
key message of ‘taking responsibilities for the social relations of science and 
technology’. This is suggestive of a rallying call for contemporary artists to operate 
outside a conventional definition of art, as offered in the Concise Oxford English 
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Dictionary: ‘the expression or application of human creative skills and imagination, 
typically in a visual form producing works to be appreciated primarily for their beauty 
or emotional power’. This definition follows a Kantian perspective, which has several 
principles in mind. Kant’s aesthetic experience can be an experience of beauty or the 
sublime, that is of disinterested pleasure. Aesthetic judgement in this view is 
subjective but universally valid. Art is for all so it is not socially constructed. The 
autonomy of art saves art from instrumental uses and emphasizes a non-utilitarian 
orientation of art. However, the Kantian construction of art has been challenged by 
those who desire to situate the art object in a changing social context.   
Hal Foster’s (1983, xv) term ‘anti-aesthetic’, which he advanced in an 
influential volume of essays on postmodern culture, is likewise instructive. The anti-
aesthetic ‘is the sign not of a modern nihilism … but rather of a critique which 
destructures the order of representations in order to reinscribe them’. The notion of 
the aesthetic, as a network of ideas, is part of Foster’s anti-aesthetic. Foster was, like 
Haraway, critiquing the Kantian perspective on aesthetic judgement.  The anti-
aesthetic ‘signals a practice, cross-disciplinary in nature, that is sensitive to cultural 
forms engaged in a politic’; it is also ‘rooted in a vernacular – that is, to forms that 
decry the ideas of a privileged aesthetic realm’ (Foster 1983, xv). 
Both Haraway’s technoscience and Foster’s anti-aesthetic, which posit a social 
role for the artist, serve as a backdrop to address how bio and art converge and to 
explore the relationship between bio and art to create bio art. ‘The prevalence of “bio” 
words suggests that “bio” is the new “post-” or “cyber-” prefix’, according to Thacker 
(in Thacker and Ruiz 2006, 5). Thacker adds that ‘what people usually mean by 
adding “bio” is really what Aristotle means by zoê (bare, animal life)’. Bio is 
extended to include organic life with the root being the Greek bios, that is ‘the course 
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of life’, thus our understanding of biology as the ‘science of physical life, dealing with 
the morphology, physiology, origin and distribution of animals and plants’, according 
to the Concise Oxford English Dictionary. Biology as the organic world includes our 
own bodies.  
A ‘certain tonality to bio’ exists, according to Thacker (in Thacker and Ruiz 
2006, 5), namely ‘the potentially transformative or “redemptive” promises of new 
technologies’. The definition of biotechnology varies from the use of life (broad) to 
the biotech industry that emerged in the late 1970s (narrow). Moreover, a particular 
relationship between human beings and their natural world is invoked). In The Global 
Genome, Thacker (2005, xi) notes that ‘in biotechnology, ontological questions 
immediately fold onto questions that are social, economic, and cultural’. This is to 
suggest that the internal tensions are not between biology and technology, but rather 
between ‘biology and political economy’ (Thacker 2005, xix). Cultural questions 
about the nature of being human and the implications of biological manipulation as 
technology advances are raised. ‘The concept of “life itself” is being fundamentally 
transformed in the age of biotechnology’ (Thacker 2005, xii).        
‘Bio art’ (also rendered as bioart, BioArt and Bio Art) has been mooted as an 
instructive umbrella term. ‘In Bio Art’, according to Reodica (2007, 415), ‘an artist 
utilizes emerging biotechnologies from the scientific and medical fields in the 
creation of an artwork’. Spectators are presented with the complexities of ethics and 
aesthetics in a work of art; this ‘can include the methods involved with its creation’ 
(Reodica 2007, 415). Bio art practitioner Adam Zaretsky (2004, 90) stakes an avant-
garde position by reference to ‘an eclectic fecundity to guarantee iconoclasm in a 
situation’ marked by `a lack of defined aesthetics’. ‘We are major players in an 
offshoot of the art scene’, he suggests, ‘insofar as we are not making art about 
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biology. We focus on bringing our outsider ideas to life’ (Zaretsky 2004, 90). This is a 
strong statement of the art and the role of the artist in making bio art.   
A range of bio art practices – from an emerging field with artists using 
techniques associated with biotechnology in ways that create or manipulate life – 
exist, including transgenic forms, tissue culture engineering and live hybrids. First, 
transgenic forms are based on genetic engineering as it has evolved since the 1970s. A 
prime example is Kac’s GFP Bunny or Alba. Second, tissue culture engineering 
includes the artistic practice of Oron Catts and Ionat Zurr (Catts and Zurr 2001, 2002, 
2011; Zurr and Catts 2003). Catts and Zurr formed the Tissue Culture & Art Project 
that, since 1995, has had artists and researchers in residence at the University of 
Western Australia’s school of anatomy and human biology. In 2000 SymbioticA, ‘an 
innovative laboratory dedicated to researching, learning, critique and hands-on 
engagement with life sciences’, was established at UWA with Catts as director, in 
collaboration with a cell biologist and a neuroscientist. SymbioticA follows scientific 
procedures so that its projects are formed from living materials that blur the dividing 
line between art and science. For example, Pig Wings is a project, according to Catts 
and Zurr (2001), in which ‘pig’s bone marrow stem cells and three dimensional bio-
absorbable polymer scaffolds are used in order to grow pig bone tissue wings in the 
shape of the three solutions for flight in vertebrates’ to create ‘a physical human-
animal hybrid’. Tissue culture engineering also includes Reodica’s hymens. Third, 
live hybrids, which are associated with breeding ornamental plants, represent the 
lower technical end of the biotech industries. Bio art practitioners creating hybrids 
include George Gessert (1997; 1996; 1993), who breeds, makes and exhibits hybrid 
irises, and Marta de Menezes (2003), who uses butterfly wings as her canvas.2 
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Five artists as a point of entry into bio art 
 
This paper benefits from access to five artists: Oron Catts of SymbioticA, Eduardo 
Kac, Kira O’Reilly, Stelarc and Paul Vanouse.3  Our entry into bio art, including 
making initial contact with the eventual interviewees, was achieved through attending 
and participating at the ‘Eye of the Storm’ symposium at Tate Britain and ‘sk-
interfaces: exploring borders in art, technology and society’ exhibition at Casino 
Luxembourg, following an earlier version at FACT (Liverpool) in 2008. The selection 
of artists was based on recommendations and suggestions of key bio art players we 
received from attending these two events. Both were held in 2009. The artists most 
cited to us were Eduardo Kac, Oron Catts (and Ionat Zurr in the case of the Tissue 
Culture & Art Project and SymbioticA) and Marta de Menezes; George Gessert and 
Joe Davis were also noted. Together, they are considered the pioneers of using 
biotechnology as a medium of expression (Hauser 2003, 2008).  
Kac and Catts have already been introduced. Paul Vanouse and Stelarc (Smith 
2005) are also interesting cases, according to their contemporaries. Vanouse, who is 
based at the University of Buffalo’s department of visual arts, describes his interest to 
investigate the ‘intersection between big science and popular culture’. In the first 
Latent Figure Protocol (2007-09), a copyright symbol is derived from the DNA of an 
industrially-produced organism (a bacterial plasmid called pET-11a). Vanouse was 
seeking to illuminate ethical questions around the changing situation of organic life 
and the ownership of living organisms. Stelarc’s contribution to bio art follows his 
earlier practice as a posthuman performance artist. Stelarc has challenged traditional 
views of being human by advertising himself as a living cyborg (Garoian and 
Gaudelius 2001). Engaged in ‘reservoirs of organs, or bionic hybrids’ (including 
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mechanical prosthetic devices along with biological implants), Stelarc notes that he 
‘not accept the biological status quo of the body … a body augmented with 
technology becomes an extended operational system’. Finally, ‘biotechnical practices’ 
is the term Kira O’Reilly uses; she describes how her ‘body is material and also the 
site in which narrative threads of the personal, sexual, social and political knot and 
unknot in shifting permutations’.  
The selection of Catts (of SymbioticA), Kac, O’Reilly, Stelarc and Vanouse 
represent a cross-section of bio art practices. Kac, Catts and Stelarc are high-profile 
and included in other examinations of bio art (see, for example, Levy 2007). But they 
also adopt different bio art practices. Kac, who uses transgenic techniques, is the most 
ardent advocate of bio art. SymbioticA, with its interest in tissue culture engineering, 
was one of four exemplars of activist art selected for discussion by Thacker (2005) in 
The Global Genome. Stelarc has made a transition from his living cyborg persona of 
the 1980s and 1990s to bionic hybrids. Both O’Reilly, who explores the biological 
status of the body, and Vanouse, who uses DNA samples to create emergent 
representational images, are newer to the bio art community. In addition, the inclusion 
of O’Reilly alongside Stelarc accentuates skin as a technological interface, which is a 
concept of bio art. This is to say both O’Reilly and Stelarc use their own skin – the 
physical body of the artist – as a technological interface.    
Semi-structured, or focused, interviews (lasting between 45 minutes and two 
hours) were conducted in Luxembourg and Chicago with these five artists. We were 
keen to explore the perspectives of bio art, including artistic practices, with key 
practitioners. We desired to hear what each artist had to say and how s/he wanted to 
express it. At the same time, we were also interested to know if the bio art 
practitioners could confirm insights and information we had already gathered through 
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other sources of evidence, including the specialist journal Leonardo and exhibition 
histories (Regine 2013).4  Such knowledge provided a check on the reliability of the 
interview data.  
We are also aware that the bio art practitioners – informants who are also 
actors in our paper – are interested in how their artistic practices are viewed. Specific 
framing devices (which we return to later) are used in order to provide an analytical 
perspective in our discussion of biotech aesthetics. We believe it is important to 
consider bio art within a history of contemporary art production in the twentieth 
century; this invites discussions and debates by contemporary theorists of art. Bio art 
practitioners are keen to be considered artists so this framing or bracketing is not an 
artificial imposition; rather it is a logical consequence of them being assessed as 
contemporary artists. This militates against an uncritical acceptance of the interview 
data associated with becoming too dependent on informants. It also strengthens the 
validity of the study by presenting a picture that is not entirely biased by the bio art 
practitioners.   
 
Framing biotech aesthetics 
 
Bio art practitioners have adopted unorthodox materials, tools and ideas inspired by 
the worlds of science and technology. As such, and in order to contextualize bio art 
practitioners as contemporary artists, references are first made to Marcel Duchamp, a 
pioneering artist of the twentieth century, who is credited with an originality of vision 
in resisting the dominating views about art in his era. In addition, contemporary 
theorists of art, Alexander Alberro, Benjamin Buchloh, Arthur Danto, Hal Foster and 
Lucy Lippard, helped us to assess bio art practices.   
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‘By stripping bio-science of its pragmatic function and contextualizing it as 
aesthetics, gene artists reanimate issues Duchamp could have appreciated, especially 
those of authorship and originality, and the nature and purpose of art’ (Tomasula 
2002, 137). The bio art reference to Duchamp is not surprising. Duchamp, who casts a 
long shadow over contemporary art practices, has been reborn for each new 
generation of artists. Duchamp plays an important art-historical role, of transforming 
objects from commonplace existence into works of art (Danto 1981). Duchamp’s 
Fountain (1917) – based on the artist purchasing a urinal, turning it upside down, 
baptizing it Fountain and signing it ‘R. Mutt’ before entering it into an exhibition 
where it was rejected – remains his most well-known readymade.5  This act 
represented a shift from facture – inscriptions of the hand of the artist as a sign of 
artistic production – to the role of the artist in determining an idea or concept. His 
artistic decision led to a charge of plagiarism, to which he issued a robust rebuttal 
(Duchamp 1917):  
Whether Mr Mutt with his own hand made the fountain or not has no 
importance. He CHOSE it. He took an ordinary article of life, placed it so 
that its useful significance disappeared under the new title and point of 
view – created a new thought for that object (emphasis in the original).  
Danto (1981) recognized that Duchamp’s work was not the urinal at all but the 
gesture of exhibiting it. Similarly, Duchamp, for Foster (1985), renounced so-called 
retinal painting and exhibited readymades in such a way as to debunk the 
transcendental pretensions of the art object. Forty years after Fountain, Duchamp 
(1957) would describe ‘the creative act’ as how ‘the artist goes from intention to 
realization through a chain of totally subjective reaction’. 
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However, it is important to remember that the reception of Duchamp – as the 
Duchamp we now know – was not immediate. Buchloh (1990) traces Duchamp’s 
contemporary reception to the early 1960s and the formation of conceptual art. The 
dilemma of artistic production raised by Duchamp’s readymades is, according to 
Buchloh, the conflict between structural specificity and random organization. The 
Duchampian tradition is to assign a new idea or meaning to an object randomly as 
though the object were an empty linguistic signifier. In particular, Robert Morris’ 
early work (1961-63) has been posited by Buchloh (1990, 115) as marking an 
‘understanding of Duchamp that transcended the limited definition of the readymade 
as the mere displacement of traditional modes of artistic production by a new 
aesthetic of the speech act (“this is a work of art if I say so”)’. Morris ‘renewed the 
Duchampian quest for a nonretinal art’ (Buchloh 1990, 116). Yet Buchloh (1990, 142-
143) also recognized the short-lived triumph of conceptual art in the transformation of 
audiences and reception and the abolition of object status and commodity form. 
There are affinities between conceptual art, particularly as articulated by 
Lippard and Chandler (1968) and Alberro (2003; Buchloh et al. 1990), and bio art. 
Lippard and Chandler (1968) advanced the dematerialization of art. In doing so, 
Lippard and Chandler (1968, 32) drew on the framework of Joseph Schillinger (1895-
1943), who advanced ‘the abstraction and liberation of the idea’ in The Mathematical 
Basis of the Arts. According to Lippard and Chandler (1968), some works of art may 
emphasize the thinking process almost exclusively. Detractors argue that such ideas-
based works are not aesthetic. They mean there is not enough for the eye to look at. 
This echoes a criticism of Duchamp and his readymades, namely that attention is 
devoted to nonretinal art, thus challenging spectators to revise their concept of art 
(namely a retinal art that gratifies the eye).  
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On the emergence of conceptual art, Alberro (2003, 55) discusses ‘an art that 
degraded traditional materials, surfaces, and self-contained forms in favor of media 
not previously associated with art, and of an unprecedented transparency of operative 
structures of signification’. In many respects this description includes bio art, with its 
use of biotechnology as a medium of expression (whether transgenic forms, tissue 
culture engineering or live hybrids) not usually associated with art.  
‘The withdrawal of the experience of aesthetic pleasure from art’ is one 
meaning of conceptual art, according to Alberro (in Buchloh et al. 1994, 132), as our 
epigraph has already suggested. A not dissimilar spectator response was offered by 
the director of Trinity College Dublin’s Science Gallery (in Catts and Zurr 2011), in 
reference to an exhibition celebrating the first decade of SymbioticA: ‘There is 
something that makes us a little uneasy, perhaps even queasy about the idea of 
creating art works from living tissue’. Alberro (2003, 56) also emphasizes ‘the 
problem of presentation’, namely exhibition and production practices of the late 1960s 
(see Lippard and Chandler 1968) which meant that art did not need to be hung. The 
living and semi-living nature of bio art has posed challenges in terms of where and 
how to display works.    
This preliminary framing of biotech aesthetics, drawing on Duchamp, 
Buchloh, Lippard and Chandler and Alberro, allows us to develop three domains: 
artists talking about bio art; art and science intersections; and the distribution and 
reception of bio art. Below we address the theoretical dimensions suggested in each of 
the three domains.  
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Domain one: artists talking about bio art  
 
What to make of Kac’s assertion to us that ‘bio art is something new, is something 
that we don’t have from Duchamp, we don’t have from Picasso … we don’t have 
from anybody and none of these artforms lead directly to it because they’re all either 
counter to representation or based on representation’? This claim of exceptionalism 
should be viewed within an art world discourse. It is an attempt to fashion bio art as a 
new avant-garde, with Kac assuming the persona of ‘outsider-artist’ (see Thacker 
2003a). As noted earlier, in defining bio art, Adam Zaretsky (2004, 90) presents 
fellow bio art practitioners as ‘major players in an offshoot of the art scene’ and 
‘bringing our outsider ideas to life’. We should locate bio art practices as having 
affinities with Foster’s description of the anti-aesthetic (as developed earlier). For 
example, bio art practices are ‘cross-disciplinary’ and ‘engaged in a politic’, with 
contemporary visual artists drawing on advances in biotechnology to create works 
made out of living materials (Foster 1983, xv). Moreover, the aesthetics of the biotech 
industry result in works that ‘decry the ideas of a privileged aesthetic realm’ (Foster 
1983, xv). In a similar manner, Lippard and Chandler (1968, 36) referenced 
Schillinger’s ‘perfect art product’ as one that allows ‘intellectual and aesthetic 
pleasure [to] emerge ... when the work is both visually strong and theoretically 
complex’. This resonates with the ambitions, according to its practitioners, of creating 
living and semi-living bio art.    
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Domain two: art and science intersections 
 
In his essay, ‘The artworld’, Danto (1964, 575) raises a point relevant to bio art 
practitioners as they grapple with relationships between art and science: ‘To mistake 
an artwork for a real object is no great feat when an artwork is the real object one 
mistakes it for. The problem is how to avoid such errors, or to remove them once they 
are made’. One is reminded that Danto’s essay – written in direct response to 
Warhol’s Brillo Box (1964) – helped to articulate the necessity of understanding the 
historical-theoretical context of a work in order to consider it as art (see, for example, 
van Maanen 2009). The distinction between Warhol’s Brillo Box as art and an 
ordinary Brillo box is due to a certain theory of art, according to Danto (1964, 581), 
as ‘it is the theory that takes it up to the world of art, and keeps it from collapsing into 
the real object which it is …’. In a similar manner, Kac’s GFP Bunny is not just a 
rabbit that glows green. In the world of art, it is the concept of art that keeps art from 
collapsing into reality. Kac’s status as an artist – as opposed to being a scientist, for 
example – also depends on the concept of art and being able to situate his bio art 
practice as a response to earlier artists.   
But why does art invite philosophical treatment? Danto (1974, 139) suggests 
an ontological classification between mere things (the so-called commonplace) and 
works of art: ‘Art works may indeed reject interpretation but are of the right sort to 
receive them’. In discussing the transfiguration of the commonplace Danto posits that 
the kind of meanings embodied by art objects are, generally, meanings having to do 
with views on art. There is art that is about art; and there is art that is about the larger 
issues of life and death. A link exists if, when the artist makes us think about art, s/he 
also inspires us with a new attitude or approach to our lives. That bodies are 
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biological and cultural, for example, is central to Reodica’s hymNext: the work of art 
is sculpted from her own vaginal cells to question the traditional value of virginity. 
This is about externalizing a particular way of viewing the world.        
 
Domain three: the distribution and reception of bio art 
 
One is reminded that the site of engagement for bio art such as Dublin’s Science 
Gallery (which describes itself as ‘a world first – a new type of venue where science 
and art collide’) – or other prominent venues like Ars Electronica (a digital arts and 
media culture centre, in Linz, Austria), FACT (Liverpool), Casino Luxembourg and 
Tate Britain – is the art institution. This situates bio art within an art world context 
(see, for example, van Maanen 2009). In particular, distribution (or intermediation) is 
about exposure and reputation. Audience reception is core to validating artists, 
according to Duchamp (1957): 
In the final analysis, the artist may shout from all the rooftops that he is a 
genius: he will have to wait for the verdict of the spectator in order that his 
declarations take a social value and that, finally, posterity includes him in 
the primers of Artist History. 
Rosiland Krauss (in Buchloh et al. 1994, 137) recognized that the reception of 
Duchamp valorizes the importance of reception. However, a fallacy of the early 
interpretation of Duchamp’s readymades was to obscure the institutional and 
discursive framing conditions. Yet it is precisely these framing conditions that have 
allowed the readymades to generate shifts in the assignment of meaning to include 
nonretinal art; this also allowed and the experience of the object, particularly one that 
is made theoretically complex by the artist, as a work of art (Buchloh 1990, 138).  
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Bio art can be an act of resistance, suggestive of both Foster’s anti-aesthetic 
and Haraway’s technoscience, a desire to change the art object and its sociopolitical 
context. In addition, bio art objects, certainly ones which are living, place different 
requirements on the spectator in order to experience the work. Lippard and Chandler 
(1968) suggested greater participation is required of the spectator owing to the 
temporal nature of works that dematerialize. Such a heightened act of looking by 
viewers also applies to bio art works.  
Having addressed theoretical dimensions in each of the domains, we proceed 
in the next three sections to advance each domain: artists talking about bio art; art and 
science intersections; and the distribution and reception of bio art. For each domain 
we draw on the interview data in order to contextualize bio art practitioners and their 
art projects.  
 
Artists talking about bio art 
 
Of the interviewed artists, Kac is the only one who readily identifies himself as a bio 
art practitioner: ‘Bio art is like video art: it’s clear, it’s unambiguous, it’s short, it’s 
direct, it’s easy and that’s why it has gained currency’. Others prefer ‘biological arts’ 
(Catts), ‘emergent media’ (Vanouse) and ‘medical artist’ (Reodica). Indeed O’Reilly, 
who also uses the descriptors ‘biological arts’ and ‘emergent media’, notes that her 
work is often referred to as ‘live art’: ‘I love it when different artists use different 
words to describe their practices even if they’re in similar realms. It allows us to play 
with language and representation’. All accept that the term bio art has gained 
recognition as a shorthand description. So what is bio art? Is bio art a movement, a 
tendency or style in art with a specific common philosophy or goal?   
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Catts finds the act of defining bio art ‘problematic’, referring to himself as ‘an 
artist who engages with biological arts’, and signalling the choice of media as a 
defining factor. He describes the process of deciding who to accept at SymbioticA 
based on who can make use of the available laboratory resources: ‘It’s not so much an 
ideological definition or something which is based on any type of manifesto, it’s 
really about access to resources, it’s a very pragmatic kind of approach’. In addition, 
Catts notes that subject matter and media are ‘almost identical in a sense’. Vanouse 
defines bio art as ‘being’ and says that ‘it can be about the sort of space between 
things, between inert and live things’.  
Artistic practices by Stelarc and O’Reilly, who have as aforementioned 
backgrounds exploring the concept of skin as a technological interface including self-
experimentation, are part of inquiries into what a body can do. Stelarc describes bio 
art as ‘using living material, and using it in such a way that you can create sort of 
sculptural forms that weren’t possible before … that allows you to explore the notions 
of what’s alive, what’s dead, what’s partially living’. Similarly, following a residency 
at SymbioticA in 2004 working with pig’s tissue in a laboratory setting, O’Reilly has 
explored the similarities between a dead pig’s skin and her own in an intimate and 
controversial performance, inthewrongplaceness (2005-09). She says of this work:  
I move it around the space over four or five hours. The audience can touch 
my body and the pig’s body, so it’s a very visceral encounter. 
There’s no technology involved whatsoever, but its genesis is from 
animal research and science in the laboratory.  
All the interviewed artists acknowledge they have relationships and exchanges 
with each other. But do the artists view themselves as representing an art movement? 
Or is this the wrong question?  The very idea of an art movement has been described 
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as a ‘residual of modernist nostalgia’ (Davis and Morris 2007, 416). Indeed when 
asked if they viewed themselves as part of a cohesive movement, the artists responded 
with some disdain. ‘I don’t think it would be very interesting if that was the case’ said 
Stelarc, who continued, ‘we do very much come from different directions’. Likewise 
for Catts: ‘There’s no one direct kind of philosophy that drives us’; they are ‘a bunch 
of people bundled together’. O’Reilly refers to a ‘partnership’, and a ‘happy sort of 
convergence of ideas but also divergences’.  
Most of the artists associated the existence of an art movement with writing a 
manifesto. Kac makes this explicit: ‘The existence of a traditional early twentieth 
century apparatus shall not be the guiding principle to define whether or not we are 
looking at a movement’. Notions of community and cohesion are suggestive, though. 
Vanouse describes artists working in bio art as a ‘cohesive community’: ‘One of the 
things that makes movements cohesive is when they’re very much outside of the 
realm of the rest of the arts. We’ve been in the same ghetto together for some time’. 
Vanouse also emphasizes the high level of engagement by bio art practitioners. This 
includes ‘assertive and engaged writings’, according to Kac, ‘that establish concepts 
and parameters, inform the public of the new aesthetics, put concepts in circulation, 
and coin words’. In bio art, with its attention to ideas and the thinking process, the 
artist is also a writer.  
Two positions emerge from these data: bio art cannot be an art movement 
because it does not have a manifesto; bio art is an art movement as represented by a 
cohesive community. Kac attempts to clarify the situation: ‘Bio art is the first art 
movement of the twenty-first century, a movement that doesn’t need the traditional 
manifesto’. There is an artistic community of bio art practitioners engaged in a newly 
serious purpose, namely the creative use of biotechnology. ‘We see a group of artists 
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who have exchanges on many levels. There is a common aesthetic, but not in the 
specific outcome of each artist’, according to Kac.  
 
Art and science intersections 
 
As we have argued earlier, art projects from living material blur the dividing line 
between art and science. ‘Bio art stands with feet in both worlds’ (Wilson 2002, 23). 
For example, SymbioticA, according to Catts, ‘enables direct and visceral 
engagement with scientific techniques, using the discipline of art and life sciences’. 
Catts also notes that bio art practitioners ‘engage and manipulate life but also present 
this manipulated life in an artistic situation’. For Kac ‘these [biotechnology] tools are 
used because the kind of work you want to make is of that kind’. However, ‘the work 
is not identical to the process that leads to its making’.  
Bio art practitioners may also contribute to science. Art characteristics useful 
for research in the commercial and scientific worlds include ‘a tradition of 
iconoclasm’, ‘the valuing of social commentary’ and ‘the valuing of creativity and 
innovation’ (Wilson 2002, 38). According to Catts, ‘What bio artists do is allow 
scientists to look at the implications of their work in a different light and look at how 
knowledge can be applied in so many different ways’.  However, the manipulation of 
life by artists – or the removal of scientific utility from biotechnologies – can make 
bio art practitioners appear frivolous.  For example, Levy (2006) notes that bio art 
practitioners have ethical responsibilities: they are using scientific resources that 
would be expected to yield more productive inquiries if used by scientists.  
Yet these five bio art practitioners do not view themselves as practising 
science at all, even though they may be faculty members of university science 
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departments (Catts) or working with scientists (Kac, Stelarc and Vanouse). At the 
same time, Kac (like his fellow artists) acknowledges biotechnology as a point of 
reference: 
I use the media of my time to make art, as Nam June Paik used video, 
László Moholy-Nagy used the photogram and the Impressionists used new 
paints in tubes. It will be obvious in about one hundred years, or even fifty 
or … when the novelty wears off and the artwork stands on its own. 
Though not practising science, these bio art practitioners have a positive attitude to 
and respect for science. Stelarc acknowledges his scientific collaborators: ‘I respect 
the researchers that I work with. They’re essential to facilitate, assist and realize some 
of the works’. However, there is frustration that bio art work is labelled ‘part of 
science’ (Catts) or ‘artistic research’ (Stelarc). This annoys Stelarc, who sees a 
fundamental difference between the way art and science operate: 
We were talking [before the interview] about this irritation I have that for 
universities to authenticate artistic practice they have to justify or re-
categorize it as a form of research. …. We also explore and test and 
experiment, but, as artists our agenda is very different. The trajectory of art 
is to unsettle, to surprise, to shock, to provide alternative paradigms. 
Catts concurs: ‘I managed to offend quite a few [art world] people by responding 
“you obviously don’t know what science is if you think that what we’re doing is 
science”’.  
 Bio art, though, does have some of the ethical scrutiny, health and safety 
encumbrances and funding dilemmas associated with scientific experimentation. 
Ethical approval is required from universities or other funding bodies. For example, 
bio art practitioners must obtain permission to perform biopsies on themselves in 
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order to create works using their own genes. ‘To my surprise they seem to be very 
accommodating to our wildest proposals. ... but sometimes I wish that the ethics 
committee [at UWA] would actually be there to question some of the things that are 
happening’ (Catts). (This suggests that Catts desires an opportunity for an engaged 
exchange with university colleagues on the ethics of bio art practices. Doing so would 
involve the science and non-science communities.) Health and safety hurdles facing 
bio art practitioners for the public display of works can also be high. Kac was 
awarded the Golden Nica for hybrid art at Ars Electronica in 2009 for Natural History 
of the Enigma (2003-08). However, the central work Edunia – the transgenic hybrid 
between Kac and a petunia flower – required multiple approvals to be granted in order 
for it to be shown.  
It is, moreover, not surprising that these bio art practitioners have mixed views 
on accepting commissions to fund works. Kac’s Cypher (2009) and Natural History 
of the Enigma (2003-08) were commissioned by French contemporary art centre 
Rurart and the Weisman Museum in Minneapolis, respectively: 
I accepted the commission to make a sculpture, but explained that I don’t 
work that way. I don’t just make forms like that. To me there’s a process 
that begins with the creation of new life. That alone will suggest pathways 
that I haven’t anticipated. 
Five years later, the Weisman Museum received, as part of its permanent collection, 
Edunia and a colossal fibreglass and metal sculpture. In a similar manner, Vanouse, 
who has had several commissions including one from the Henry Art Gallery in 
Seattle, is positive about the funding experience: ‘Arts grants are pretty loose. They 
generally will let you change your ideas midway through and things like that’. On the 
other hand, Catts has refused commissions in his position as director of SymbioticA, 
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including one from PETA (People for the Ethical Treatment of Animals); at the same 
time, PETA has criticized bio art practitioners. Catts feels the need to ‘try to maintain 
at least an appearance of autonomy and being able to engage in a non-agenda based 
way so we tend to avoid things that might compromise both this perception and the 
ability for artists to explore what they want’.  
 Stelarc has sought commercial collaboration even though most of his projects, 
such as the Third Hand, the Walking Head Project and Blender, have not received 
external funding. This is to say self-funding has been essential. Nonetheless, Stelarc’s 
Ear on Arm was funded by the Discovery Channel as part of a documentary on 
experimental surgery; it represents the most commercial transaction in bio art funding 
thus far. Stelarc’s experience with the Discovery Channel also illustrates the impact 
funding can have on an artist: ‘I thought the documentary sucked big time ... but it did 
allow me enough money to do the project’. Stelarc was frustrated that the 
documentary did not show as much of the surgery as he wished. He insisted on high-
definition footage of the surgery, which he has been able to use to create videos to 
accompany exhibitions; however, he is not able to sell these videos as part of his 
contract with the Discovery Channel. 
Further, these bio art practitioners are frequently vexed if they are asked to be 
science communicators or to spark people’s interest in science. They contend that 
their work deals with the creative use of biotechnology by artists. According to Kac, 
‘Science is in the eye of the beholder, which means that you can, if you want, see 
science as everything. … But let’s be clear that you are doing that, not the artist’. ‘The 
role of bio art in science is secondary’, according to Catts, who is ‘suspicious of 
artists who claim that they’re contributing to science’.  
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The distribution and reception of bio art 
 
Audience reception depends on an artist having his or her works being exhibited. As 
such distribution in art matters a great deal, so who and what gets exhibited – 
including how and where? The five artists we interviewed wish to shape public and 
critical reception of their work. They privilege particular artistic practices of value in 
bio art. Consider Kac’s statement at the outset of our interview with him: 
There is an important difference between the market for bio art and the 
market for bio artists. When I sell a photograph, it’s a photograph even if it 
is part of the GFP Bunny series, it’s not alive. We’re only talking about the 
market for bio art when it is alive.   
This reflects the thinking process and the idea behind bio art, namely representing the 
bio-ness of the art being created. At the same time Kac – like most bio art 
practitioners – adopts artistic practices that encompass more than just biological 
processes; they may photograph, paint or sculpt as well.  
 The market for bio art refers to both living works of art, which have a lifespan, 
and works that are preserved. In addition, the work of bio art practitioners can also 
include auxiliary or documentary works. Three complementary forms of work– living, 
preserved and documented – can thus be identified. There is a challenge in each to 
conventional ways of seeing, namely in how these artists desire their works to be 
experienced by spectators. This is about artists establishing the ideal conditions for 
critical and public reception of their works.  
 First, bio art is living so it also dies. Living bio art is deemed by these artists 
as aspiring to an ideal form of bio art. This also means that the experience of these 
living works is temporal so their specific meanings fluctuate depending on when a 
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spectator experiences the work (see Lippard and Chandler 1968). Demands are placed 
on spectators as greater participation is required. The sense of duration seems longer, 
as one is being asked to view the gradual process of growth and decay in a living 
organism. In addition, it is challenging for spectators to experience the tensions 
between life and death associated with living bio art: there is a sense of control and 
immortality associated with life; at the same time, there is sense of vulnerability and 
inevitability associated with death.    
The display and collection of living bio art face difficulties. For example, 
displaying living and semi-living organisms requires sterile environments and 
bioreactors (i.e., devices used for growing and sustaining living cells and tissue 
outside of their environment) in order for them to survive. The construction of 
temporary laboratories within conventional exhibition spaces – ‘a very versatile space 
that has the same type of resources that a good biological lab would have’, according 
to Catts – has been mooted at UWA to house a permanent display of works by 
SymbioticA. Moreover, SymbioticA is working with conservators to create a ‘toolkit’ 
for artists and conservators to aid in the preservation of bio art works. At the same 
time, some works of bio art, such as Kac’s Natural History of the Enigma (2003-08) 
are very straightforward in their preservation, proving to be easier to maintain than 
traditional media like oil painting on canvas: 
The flower is in the permanent collection of the museum, in the form of 
seeds. The flower will die within a month or two, but the seeds don’t. The 
genetic sequence is also in the collection. Long after I’m gone, the seeds 
should still be good. … Natural History of the Enigma should outlast 
Velasquez by a long shot.    
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 Second, given the challenges of displaying living and semi-living works – that 
is in following their ideas through – artists have developed ways to preserve their 
works for display. For example, the Tissue Culture & Art Project developed ‘the 
killing ritual’ in order to stop the growth of works like Pig Wings and Semi-Living 
Worry Dolls (2000), which are then preserved in glycerol. Reodica employs a similar 
approach with her hymNext project by growing hymens until they reach the desired 
size; she then quickly stops their growth and coats them in latex. This is about 
locating a living bio art work at a particular point in time, with an intention that the 
spectator delves into the process of artistic production and the ideas behind the artist’s 
practice. 
Third, documented bio art reflects both technology constraints and curatorial 
choices. The result of documented bio art is often a photograph. Spectators are now 
accustomed to photography as a form of art. For example, after the Tissue Culture & 
Art Project began in the mid-1990s, Catts and Zurr had several sell-out shows based 
on large digital prints of photographs depicting their semi-living sculptures. 
According to Catts, these shows were ‘very traditional in the sense of what we were 
showing was a representation of the process ... and the objects that were developed in 
the laboratory’. It is also instructive to note that the most well-known bio art work, 
Kac’s GFP Bunny, is known to most spectators via documentation.   
Opinions about the nature of bio art works differ, though all of the practices – 
biological and non-biological – are integrated. Some artists, such as Kac and Stelarc, 
identify their non-biological works as extensions – or auxiliary works – of the 
original, living, biological ones. These auxiliary works include documentary evidence 
such as photographs and videos; lithography (Kac’s designs for his Edunia seed 
packs) and sculpture (Stelarc’s Ear on Arm casts) are also evident. As Stelarc 
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explains, ‘It is convenient to separate documentation and artwork performance. But 
I’ve never really done that. If I look at a videotape of my past performances, to me 
that documentation represents a half-life’.  
Catts feels differently, though, with much less emphasis on the documentation. 
On two separate occasions during our interview, he mentions that the Pig Wings can 
be viewed at New York’s MoMA as part of its permanent collection. Catts seems 
disappointed that the works owned by MoMA are ‘just the prints’, though. We 
interpret this as incompleteness, that the entirety of his idea cannot be communicated 
in a print. By way of explanation, Catts makes reference to Boris Groys (2008): 
Art is becoming a process and the documentation of the process is on 
display. … Groys [in Art Power] refers to the form of “liveness of the art” 
– that art goes through a living cycle or lifecycle.       
In making a case for audience participation and authenticity in the liveness of a 
concert or a reading, Groys seems to be affirming that a performance’s life is in the 
present. When a performance enters the economy of reproduction it is less alive.  
There is a similar privileging of liveness in bio art by Catts – also expressed by Kac at 
the outset of this section – with living bio art works having greater value relative to 
documented works. 
Time spent at the Harvard Medical School in the late 1990s helped Catts to 
develop new techniques; equally as important, Ars Electronica was willing to 
establish a fully functioning laboratory in an exhibition setting. This has informed 
Catts’ attitude to art market sales: 
The Tissue Culture & Art Project and SymbioticA lost interest in selling 
anything. It is much more interesting for us to show the living sculpture. 
Given our critique of the commodification of life, trying to commodify a 
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thing in an artistic context and sell it was problematic. Since 2000 I don’t 
think we’ve sold one work.   
Bio art may be one way to demonstrate the materiality of the things of this world 
beyond their monetary exchange value. Indeed all these bio art practitioners expressed 
a desire to control the conditions for the critical and public reception of their works, 
even if it means that living bio art is less saleable to private collectors and more 
challenging to spectators.  
   
Bio art: critical practice and communal ethos 
 
Art can certainly be considered one of the most powerful and recognized generators 
of meaning today. The objects created by contemporary artists can help to make sense 
of our changing world, one that is marked by rapid technological and social advances 
in the context of a globalized economy. This paper has focused on the voices and 
works of five contemporary artists – Oron Catts of SymbioticA, Eduardo Kac, Kira 
O’Reilly, Stelarc and Paul Vanouse – who travel under the banner of bio art, an 
emerging contemporary art practice of the early twenty-first century. These 
micronarratives make history of contemporary art. They also allow three domains of 
investigation to emerge with a shared focus on bio art and its practitioners: artists 
talking about bio art, art and science intersections and the distribution and reception of 
bio art. In doing so we have a better understanding of bio art as a critical practice 
based on a communal ethos. 
 Bio art is a critical practice. We mean critical in the sense that it is in 
opposition to what is viewed as dominant. Questions of bio art provoke unease.  
These are the sort of reflections by spectators – on the concept of art and the divide 
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between the arts and science – that do not sit easily within the core of disciplines (in 
the visual arts and biotechnology, for instance) and institutions (such as art museums 
and science laboratories). As live bio art is physically ephemeral by definition, there 
is a question of whether the idea of bio art can remain in effect even after the work 
itself has disappeared. Bio art invites one to consider, as outlined by Lippard and 
Chandler (1968), how the judgement of an idea is less interesting than following the 
idea through. In the process of following an idea through, one learns if it is a good 
idea (that is fertile and open enough to suggest infinite possibilities such as offered by 
the legacy of Duchamp’s readymades), a mediocre idea (that is exhaustible) or a bad 
idea (that is already exhausted or with little substance). As a form of cultural 
expression the idea of bio art is to explore the living and partially living by creating 
works of art. There are opportunities for bio art practitioners to follow their ideas 
through more fully.   
Contemporary artists addressing science and technology have, we suggest, a 
distinctive sociopolitical role. There is often an overly positive attitude toward science 
and technology, related to the self-congratulatory and enthusiastic accounts scientists 
often give of their own disciplines. Artists can offer different sorts of narratives in this 
regard: ‘Bio art results in artistic forms of expression and sculptural objects and new 
ways of exploring the living and the partially living’, according to Stelarc. It is a way 
for artists to construct their practices and their domains of knowledge while entering a 
debate on the subject of biotechnology with the rest of the population. Such narratives 
help to bridge the gap between the ‘two cultures’ of science and the arts, expressed as 
a lament by C.P. Snow in his 1959 Rede Lecture, ‘The Two Cultures of the Scientific 
Revolution’ (see Davis and Morris 2007; Wilson 2002). The bio world involves 
complex science and technology that is often beyond the capacity of non-scientists to 
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discuss and communicate comfortably and with clarity. Artists who are able to engage 
with biotechnology in a creative manner can serve as catalysts.      
A communal ethos imbues how the bio art practitioners we interviewed 
discuss what they do, why and how they work. Transnational exchanges occur in bio 
art: strong European roots are evident, such as exhibitions and conferences, even 
though Anglo-American identities feature in the practitioners. There is convergence 
and divergence. Artists come from different directions and there are no specific 
outcomes in bio art. There is no manifesto; even calling bio art a movement does not 
garner unanimous support. There are individual actions and practices of the artists. 
However, there is a common aesthetic including the creative use of biotechnology (or 
the removal of scientific utility from biotechnology to create works of art). Bio art 
practitioners seek to serve as a community of interpreters between disciplines. There 
are notions of community and cohesion. The language is of mutual respect and 
support.  Human relations are marked by friendship, trust and virtue.  
Bio art is suggestive of permeability between disciplines. Yet interdisciplinary 
activity also proves to be difficult. Bio art practitioners invite criticisms as 
biotechnology, according to Thacker (2003b, 94), ‘is about a fundamental 
reconfiguration of the very progresses that constitute the biological domain’. Several 
criticisms and responses are presented as part of a rounded discussion.  First, bio art is 
based on an infringement upon nature, one that transgresses boundaries between the 
natural and artificial worlds (see, for example, Thacker 2003a in response to Rifkin 
2003). In this scenario, transgression is negative: it goes beyond the bounds set by the 
western edifices of humanity and humanism and has links to eugenics. An alternative 
and positive use of transgression, of the outsider-artist position, has been proffered. 
Kac ended our interview by reiterating the role of social relations in his bio art 
 33 
practice (with reference to Alba): ‘The works have to be alive and independent from 
you. They have to have a life of their own. So it’s not that they are sharing their lives 
with you, but you with them as well’. Likewise, in their curatorial statement for 
‘Visceral: the living art exhibition’ (2011), to celebrate the first decade of 
SymbioticA, Catts and Zurr (2011) articulate ‘a series of provocations and puzzles 
around the nature of living and non-living, asking us to consider the myriad of 
possible implications of our new biological toolkit’.  
A second criticism is that bio art is driven by economic imperatives such that 
it is public relations for the biotech industry (see, for example, Thacker 2003a in 
response to Rifkin 2003). Catts counters such utilitarian readings by suggesting that 
‘bio artists make scientists more aware of the social role they’re playing and not just 
as value-free knowledge producers’. Stelarc addresses the charge with his current 
artistic practice ‘of not accepting the biological status quo of the body … rather a 
body augmented with technology becomes an extended operational system’. 
Furthermore, according to Stelarc, ‘Bio art challenges not only our aesthetic but also 
our conceptual paradigms of what life is and what a body is and what constitutes life’.    
Lack of public access to documentation of the scientific procedures conducted 
as part of bio art practices – with the focus instead being on the artists declaring the 
result in works of art – is a third, and final, criticism (see, for example, Levy 2006; 
2007). Unless ethical considerations are addressed, there is an emphasis on technical 
issues that can result in bio art practitioners being perceived as advocating a more 
advanced biotechnology as the answer, what Thacker (2003b, 6) labels ‘technophilia’. 
Documentation would also offer fuller recognition of scientific collaborators in the 
creative process, as with living bio art, where art production and exhibition coincide. 
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Notwithstanding one’s sense of aesthetics and perceptions of art, which may 
be considerable, bio art aids our understanding of works of art as social and political 
objects. In navigating what is a complex and changing landscape, the social cohesion 
and trust bio art practitioners have developed as a community is beneficial if we 
accept that they are contribute to sociopolitical visions social sciences.  
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Image 1: Kac, GFP Bunny (2000) 
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Notes 
                                                 
1 Barbara Kruger’s Untitled (Your body is a battleground) was designed for the 1989 
march on Washington, D.C., in support of women’s rights and the abortion-rights 
movement.   
2 George Gessert, who started breeding ornamental plants in his garden in Eugene, 
Oregon, had his first exhibitions in the late 1980s. Comparisons have been drawn to 
photographer Edward Steichen’s exhibition of delphiniums as a form of genetic art at 
New York’s Museum of Modern Art in 1936 (see Youngs 2000). Marta de Menezes 
has adopted butterfly wings as her canvas. She uses a needle coupled with a heat 
generator to alter the wing patterns of butterflies; this is not a genetic process, though, 
as each butterfly retains its natural origin.  
3 For representations of works by the five artists, see their individual websites: Catts 
http://www.tca.uwa.edu.au/ and http://www.symbiotica.uwa.edu.au/; Kac 
http://www.ekac.org/; O’Reilly http://www.kiraoreilly.com/blog/; Stelarc 
http://stelarc.org/_.swf; and Vanouse http://www.contrib.andrew.cmu.edu/~pv28/. 
4 The we-make-money-not-art.com website includes bio art as a category, with Regine 
serving as a writer on bio art dating back to 2007. 
5 The name readymade derives from Duchamp’s practice of selecting a mass produced 
item, such as a urinal or bottle racks, to be a work of art. Fountain (1917) is the most 
famous readymade. (The original from 1917 is known to us primarily from a 
photograph taken by Alfred Stieglitz; the original was lost with replicas authorized by 
Duchamp in the mid-1960s.) Duchanp had a distaste for retinal art (or art that 
gratified the eye). With the readymade, Duchamp isolated the commonplace, 
prefabricated object from its functional context; and he elevated the object to the 
 43 
                                                                                                                                            
status of art by this act of artistic selection. For Duchanp, the readymade subtracted 
from the concept of art everything to with the artistic. In doing so, Duchamp was 
challenging the boundaries of art (which has continued to occupy subsequent 
generations of contemporary artists).  
 
 
